Jefferies Financial Group Cuts Bristol-Myers Squibb (NYSE:BMY) Price Target to $68.00
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price reduced by Jefferies Financial Group from $70.00 to $68.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on BMY. Truist Financial […]
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price reduced by Jefferies Financial Group from $70.00 to $68.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on BMY. Truist Financial […]
